Native Proteins for Respiratory Disease Research
From chronic lung conditions to infectious diseases, pollutant-induced respiratory issues, and cancer, Athens proteins underpin translational research, biomarker validation, diagnostic development, and drug discovery programs.
The Athens Advantage:
- Broad respiratory research product portfolio, spanning immune mediators, glycoproteins, proteases and inhibitors, extracellular matrix components, and transport proteins
- Native structure and activity, preserving biological function essential for robust respiratory disease research and assay development
- High purity and lot-to-lot consistency, ensuring confidence in signal stability from research through manufacturing workflows
- Scalable supply and batch reservations from single or pooled donors, supporting long-term respiratory disease research and product development
Explore how researchers worldwide have used Athens products to power pulmonary disease research: - Chen, et al. developed breath-based biosensors for lower respiratory tract infection detection1
- McCall, et al. characterized anti-peroxidasin autoantibodies associated with pulmonary–renal disease activity and pathogenesis2
- van den Berg, et al. identified neutrophil serine proteases as drivers of impaired immune signaling in cystic fibrosis and sepsis3
Want a deeper look?
Explore peer-reviewed pulmonary disease research featuring Athens proteins.
*1. Chen, et al. A breath-based in vitro diagnostic assay for the detection of lower respiratory tract infections. PNAS Nexus, 2024, 3, 350. https://doi.org/10.1093/pnasnexus/pgae350 / Maryland, USA
*2. McCall, et al. Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes. JASN, 2018, 29(11), 2619-2625. https://doi.org/10.1681/ASN.2018050519
*3. van den Berg, et al. Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor. J Immunol. 2014 Feb 15;192(4):1787-95. https:/doi.org/10.4049/jimmunol.1301920
